Is My Molecule Suitable for an Orally Disintegrating Tablet?
Summary:Orally Disintegrating Tablets (ODTs) are a patient-preferred dose form that offers additional potential benefits related to pregastric API delivery and absorption. While new drug products may benefit from ODT formulation beginning with product launch, ODT formulation can also play a role in life cycle management of approved products. API suitability for an ODT is dependent on multiple factors, including delivery target and physicochemical profile. New advances are also being developed to expand the potential of this technology.